Costs of Opioid Crisis Too Costly for Drugmakers?

A lawyer for New York State claims that the public costs of the opioid epidemic “dwarfs” the resources of all defendant opioid drugmakers combined.

The attorney, David Nachman made the comment after a judge asked him if the total public cost of the crisis should be estimated before the trial set for April or May. 

Nachman claimed that the excessive costs were simply “the reality of the opioid litigation.”

The judge also declined to hear arguments for Purdue due to their hearing in New York bankruptcy court. The company wants the injunction protecting them from creditors extended to cover their owners, the Sackler family. 

Read More from Source

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button